The molecular pathophysiology of the congenital dyserythropoietic anemias

先天性红细胞生成障碍性贫血的分子病理生理学

基本信息

  • 批准号:
    10407619
  • 负责人:
  • 金额:
    $ 61.47万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-06-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Project Summary Anemia due to defects in erythropoiesis (red blood cell [RBC] production) is a major source of mortality and morbidity worldwide. The Congenital Dyserythropoietic Anemias (CDAs) are a group of disorders of terminal erythroid maturation defects characterized by ineffective erythropoiesis and distinctive bone marrow (BM) find- ings. CDAII is the most common CDA subtype, followed by CDAI. CDAII is an autosomal recessive disease resulting from loss-of-function mutations in SEC23B, encoding a core component of coat protein complex-2 (COPII) vesicles, which transport secretory proteins from the Endoplasmic reticulum (ER) to the Golgi appa- ratus. CDAI, also an autosomal recessive disease, results from loss-of-function mutations in CDAN1, encoding CODANIN1, which is proposed to play a role in chromatin assembly. Despite the identification of the genetic defects underlying CDAI and CDAII, the pathophysiology of these disorders remains unknown. CODANIN1 has been shown to co-localize intracellularly with SEC23B, suggesting that CDAI and CDAII might share a com- mon or related molecular pathogenesis. We previously generated mice with hematopoietic SEC23B deficiency; these mice did not exhibit a RBC defect. We next showed through studies in yeast, zebrafish, mice, and hu- man cells that SEC23B overlaps in function with its closely related paralog, SEC23A, and that the expression pattern of the SEC23 paralogs has shifted in evolution (SEC23B is the predominantly expressed paralog in human BM, with comparable SEC23A and SEC23B levels in mouse BM). The overall objective of this proposal is to characterize the molecular pathogenesis of the CDAs. In early preliminary results, i) we generated mice with erythroid-specific combined Sec23a/Sec23b deletion; these mice exhibit a profound erythroid phenotype; ii) we also generated mice with hematopoietic Cdan1 deletion, which demonstrate a profound hematologic de- fect. In this proposal, we aim to characterize the critical roles of CODANIN1 and SEC23 in erythropoiesis and define the extent of the hematopoietic defect resulting from Cdan1 or combined Sec23a/Sec23b deletion. We also aim to define the genetic interaction between Sec23b and Cdan1 in vivo and determine the intracellular trafficking of CODANIN1 in SEC23B-deficient versus wild-type erythroid cells. Furthermore, based on the ER- to-Golgi transport defect in CDAII and on the lysis of CDAII RBC in some acidified human sera, which suggests an RBC membrane abnormality, we hypothesize that CDAII results from impaired trafficking of one or more key cargo proteins to the RBC plasma membrane. In preliminary results we demonstrate significant depletion of only 5 proteins in CDAII compared to control RBC plasma membranes. We will expand our studies by defin- ing the secretion of these cargos in additional CDAII patient samples and we will identify the roles of these car- gos in the pathophysiology of CDAII. Our proposed studies have important implications for understanding the pathophysiology of the CDAs and are expected to lay the foundation for the development of novel therapies for these disorders, which may be relevant to other anemias resulting from defective terminal erythroid maturation.
项目摘要 红细胞生成缺陷引起的贫血是死亡的主要来源, 世界范围内的发病率。先天性红细胞生成性贫血(CDA)是一组终末期疾病 红系成熟缺陷的特征是无效的红细胞生成和独特的骨髓(BM)发现- 英格斯。CDAII是最常见的CDA亚型,其次是CDAI。CDAII是一种常染色体隐性遗传病 由编码外壳蛋白复合体-2核心成分的SEC23B功能缺失突变引起 (COPII)小泡,将分泌蛋白从内质网(ER)运输到高尔基体-APPA- 拉特斯。CDAI也是一种常染色体隐性遗传病,由编码CDAN1的功能缺失突变引起 CODANIN1,它被认为在染色质组装中发挥作用。尽管对基因进行了鉴定 CDAI和CDAII的缺陷,这些疾病的病理生理学仍不清楚。CODANIN1有 与SEC23B在细胞内共定位,表明CDAI和CDAII可能共享COM- MON或相关分子发病机制。我们先前建立了造血性SEC23B缺陷小鼠; 这些小鼠没有表现出红细胞缺陷。接下来,我们通过对酵母、斑马鱼、小鼠和人的研究展示了 SEC23B与其密切相关的Paralog SEC23A在功能上重叠的MAN细胞,并且表达 SEC23Paralog的模式在进化中发生了变化(SEC23B是主要在 人骨髓,与小鼠骨髓中SEC23A和SEC23B水平相当)。这项提案的总体目标是 目的是研究CDA的分子发病机制。在早期的初步结果中,i)我们培育了小鼠 具有红系特异性的Sec23a/Sec23b联合缺失,这些小鼠表现出深刻的红系表型; Ii)我们还产生了造血细胞CDAn1缺失的小鼠,这表明了一种严重的血液学破坏。 完美无瑕。在这项建议中,我们的目标是表征CODANIN1和SEC23在红细胞生成和释放中的关键作用。 确定由CDAN1或Sec23a/Sec23b联合缺失引起的造血缺陷的程度。我们 还旨在确定Sec23b和CDan1在体内的遗传相互作用,并确定细胞内 CODANIN1在SEC23B缺陷型与野生型红系细胞中的转运此外,基于ER- CDAII的TO-Golgi转运缺陷和某些酸化的人血清中CDAII RBC的裂解 一种红细胞膜的异常,我们假设CDAII是由于一个或多个 红细胞膜上的关键货运蛋白。在初步结果中,我们显示出显著的耗竭 CDAII中仅有5种蛋白质与对照红细胞质膜相比。我们将通过定义以下内容来扩展我们的研究- 在额外的CDAII患者样本中检测这些货物的分泌物,我们将确定这些CAR的作用- GOS在CDAII病理生理学中的作用我们建议的研究对理解 CDA的病理生理学,有望为开发新的治疗方法奠定基础 这些疾病可能与其他由红系终末成熟缺陷引起的贫血有关。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rami Khoriaty其他文献

Rami Khoriaty的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rami Khoriaty', 18)}}的其他基金

University of Michigan Kidney, Urology and Hematology Research Training Network
密歇根大学肾脏、泌尿科和血液学研究培训网络
  • 批准号:
    10705174
  • 财政年份:
    2022
  • 资助金额:
    $ 61.47万
  • 项目类别:
The regulation of thrombopoietin levels
血小板生成素水平的调节
  • 批准号:
    10457889
  • 财政年份:
    2021
  • 资助金额:
    $ 61.47万
  • 项目类别:
The regulation of thrombopoietin levels
血小板生成素水平的调节
  • 批准号:
    10177289
  • 财政年份:
    2021
  • 资助金额:
    $ 61.47万
  • 项目类别:
The regulation of thrombopoietin levels
血小板生成素水平的调节
  • 批准号:
    10590666
  • 财政年份:
    2021
  • 资助金额:
    $ 61.47万
  • 项目类别:
The molecular pathophysiology of the congenital dyserythropoietic anemias
先天性红细胞生成障碍性贫血的分子病理生理学
  • 批准号:
    10165812
  • 财政年份:
    2019
  • 资助金额:
    $ 61.47万
  • 项目类别:
The molecular pathophysiology of the congenital dyserythropoietic anemias
先天性红细胞生成障碍性贫血的分子病理生理学
  • 批准号:
    10618313
  • 财政年份:
    2019
  • 资助金额:
    $ 61.47万
  • 项目类别:
The Evolution of the Mammalian SEC23 Paralogs and the Molecular Pathogenesis of Congenital Dyserythropoietic Anemia type II
哺乳动物 SEC23 旁系同源物的进化和先天性红细胞生成不良性贫血 II 型的分子发病机制
  • 批准号:
    8947436
  • 财政年份:
    2015
  • 资助金额:
    $ 61.47万
  • 项目类别:
The Evolution of the Mammalian SEC23 Paralogs and the Molecular Pathogenesis of Congenital Dyserythropoietic Anemia type II
哺乳动物 SEC23 旁系同源物的进化和先天性红细胞生成不良性贫血 II 型的分子发病机制
  • 批准号:
    9515051
  • 财政年份:
    2015
  • 资助金额:
    $ 61.47万
  • 项目类别:
The Evolution of the Mammalian SEC23 Paralogs and the Molecular Pathogenesis of Congenital Dyserythropoietic Anemia type II
哺乳动物 SEC23 旁系同源物的进化和先天性红细胞生成不良性贫血 II 型的分子发病机制
  • 批准号:
    9298412
  • 财政年份:
    2015
  • 资助金额:
    $ 61.47万
  • 项目类别:

相似海外基金

Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
  • 批准号:
    502556
  • 财政年份:
    2024
  • 资助金额:
    $ 61.47万
  • 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
  • 批准号:
    10659303
  • 财政年份:
    2023
  • 资助金额:
    $ 61.47万
  • 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
  • 批准号:
    10674405
  • 财政年份:
    2023
  • 资助金额:
    $ 61.47万
  • 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
  • 批准号:
    10758772
  • 财政年份:
    2023
  • 资助金额:
    $ 61.47万
  • 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
  • 批准号:
    10676499
  • 财政年份:
    2023
  • 资助金额:
    $ 61.47万
  • 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
  • 批准号:
    2748611
  • 财政年份:
    2022
  • 资助金额:
    $ 61.47万
  • 项目类别:
    Studentship
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
  • 批准号:
    22K05630
  • 财政年份:
    2022
  • 资助金额:
    $ 61.47万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
  • 批准号:
    10532032
  • 财政年份:
    2022
  • 资助金额:
    $ 61.47万
  • 项目类别:
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
  • 批准号:
    10525070
  • 财政年份:
    2022
  • 资助金额:
    $ 61.47万
  • 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
  • 批准号:
    10689017
  • 财政年份:
    2022
  • 资助金额:
    $ 61.47万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了